A case-crossover study of infectious diseases and new diagnosis of type 1 diabetes

Aushrat Shoshan1, Tal Sella, Tamar Shohat

  • 1Medical Division, Maccabi Healthcare Services, Tel Aviv, 68125, Israel.

Pediatric Diabetes
|July 7, 2012
PubMed

Insights

Viral infections significantly increase type 1 diabetes (T1D) risk in young children. This study found a higher rate of viral illness in the year preceding T1D diagnosis, particularly in toddlers.

Area of Science:

  • Immunology
  • Pediatrics
  • Epidemiology

Background:

  • Infectious diseases are linked to an increased risk of type 1 diabetes (T1D).
  • Investigating infectious agents as potential triggers for T1D is crucial for understanding disease etiology.
  • Previous research suggests a correlation, but specific triggers and timing require further elucidation.

Purpose of the Study:

  • To quantify the role of infectious diseases as triggers for T1D.
  • To examine the association between infections and T1D onset in children and adolescents.
  • To determine if specific types of infections or timeframes preceding diagnosis are more strongly associated with T1D.

Main Methods:

  • A case-crossover study design was employed.
  • Identified children aged 2-18 diagnosed with T1D between 2004-2009 in a large Israeli healthcare organization (n=368).
  • Compared physician visits for symptomatic infectious diseases in the 1-2 years prior to T1D diagnosis against a matched control group (n=307).

Main Results:

  • Systemic viral infections were significantly more common in the year before T1D onset (27%) compared to the prior year (7%), with an odds ratio (OR) of 4.7.
  • This association was most pronounced in children aged 2-6 years, with viral infections preceding diagnosis in 46% of cases versus 5% in the earlier period (OR=27.0).
  • No similar increase in viral infections was observed in the control group, and the association was specific to viral diseases and young children.

Conclusions:

  • T1D in toddlers is characterized by a low incidence of viral disease two years prior to diagnosis, followed by a significant increase in the subsequent year.
  • Viral infections appear to be a critical trigger for T1D development in young children.
  • These findings highlight the importance of considering viral triggers in the pathogenesis of T1D, especially in early childhood.
Abstract

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...